Company Valuation: AstraZeneca PLC

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 182,034 209,442 209,268 203,171 287,813 267,135 - -
Change - 15.06% -0.08% -2.91% 41.66% -7.18% - -
Enterprise Value (EV) 1 206,417 232,365 231,778 227,741 311,187 286,459 278,981 270,482
Change - 12.57% -0.25% -1.74% 36.64% -7.95% -2.61% -3.05%
P/E 1,469x 64.1x 35.4x 29.1x 28.4x 21.6x 19x 16.4x
PBR 4.24x 5.65x 5.39x 5.02x 5.96x 5.04x 4.38x 3.7x
PEG - 0x 0.4x 1.6x 0.6x 1x 1.4x 1x
Capitalization / Revenue 4.87x 4.72x 4.57x 3.76x 4.9x 4.23x 4x 3.75x
EV / Revenue 5.52x 5.24x 5.06x 4.21x 5.3x 4.53x 4.18x 3.8x
EV / EBITDA 27.2x 25.2x 17.1x 13.6x 16x 12.7x 11.3x 9.98x
EV / EBIT 20.8x 17.4x 15.9x 13.5x 16.8x 13.5x 11.9x 10.5x
EV / FCF 42.4x 26.7x 25.8x 22.9x 26.5x 28.5x 21.1x 18.4x
FCF Yield 2.36% 3.75% 3.88% 4.36% 3.78% 3.51% 4.74% 5.42%
Dividend per Share 2 2.87 2.9 2.9 3.1 3.2 3.341 3.522 3.658
Rate of return 2.44% 2.15% 2.15% 2.37% 1.72% 1.94% 2.05% 2.12%
EPS 2 0.08 2.11 3.81 4.5 6.54 7.988 9.071 10.51
Distribution rate 3,588% 137% 76.1% 68.9% 48.9% 41.8% 38.8% 34.8%
Net sales 1 37,417 44,351 45,811 54,073 58,739 63,204 66,772 71,145
EBITDA 1 7,586 9,237 13,580 16,691 19,476 22,641 24,705 27,115
EBIT 1 9,928 13,350 14,534 16,928 18,478 21,168 23,414 25,728
Net income 1 112 3,288 5,961 7,035 10,225 12,432 13,937 15,996
Net Debt 1 24,383 22,923 22,510 24,570 23,374 19,323 11,846 3,346
Reference price 2 117.51 135.16 135.02 131.05 185.60 172.23 172.23 172.23
Nbr of stocks (in thousands) 1,549,159 1,549,528 1,549,926 1,550,317 1,550,726 1,551,024 - -
Announcement Date 2/10/22 2/9/23 2/8/24 2/6/25 2/10/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
34.92x12.63x25.81x0.57% 1,060B
27.42x6.3x17.1x2.08% 619B
30x7.34x15.02x2.76% 438B
17.98x4.45x11.01x2.97% 333B
21.52x5.52x13.36x2.86% 282B
14.17x5.3x10.9x3.52% 218B
23.77x6.31x11.12x2.78% 196B
-46.02x5.6x31.12x2.5% 161B
12.29x3.03x7.56x7.14% 138B
Average 15.12x 6.27x 15.89x 3.02% 382.73B
Weighted average by Cap. 23.57x 7.91x 18.16x 2.21%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield